Clinical Trial Update: Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing carboplatin–gemcitabine with cisplatin–gemcitabine as neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Bladder Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Assiut University | Conditions: Urinary Bladder Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING